Abstract
This chapter presents an overview of access pathways to high-cost medicines in Australia, including funding and pricing processes for medicines subsidised by the national pharmaceutical insurance system, the Pharmaceutical Benefits Scheme (PBS) as well as other avenues for accessing non-PBS-funded medicines. It describes current and emerging policies for facilitating access to high-cost medicines by providing better information of the public and improving engagement in decision-making.
Original language | English |
---|---|
Title of host publication | Equitable Access to High-Cost Pharmaceuticals |
Publisher | Elsevier |
Pages | 165-181 |
Number of pages | 17 |
ISBN (Electronic) | 9780128119457 |
ISBN (Print) | 9780128119624 |
DOIs | |
Publication status | Published or Issued - 1 Jan 2018 |
Externally published | Yes |
Keywords
- coverage with evidence
- funding of medicines
- high cost medicines
- pricing of medicines
- public pharmaceutical insurance scheme
ASJC Scopus subject areas
- Economics, Econometrics and Finance(all)
- Business, Management and Accounting(all)